Value Bridge — HAZEL HAWKINS MEM. HOSPITAL
Current $-24M → Target $-20M (+$3.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-23.6M
Current EBITDA
$-19.9M
Target EBITDA
+$3.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.6M
Coding Accuracy Uplift
$0.7M
Payer Mix Optimization
$1.7M
Cost to Collect Reduction
$0.6M
Clean Claim Improvement
$0.4M
Volume & Rate Growth
$2.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-24M to $-20M. The highest-impact lever is Volume & Rate Growth at $1.1M probability-weighted.
IC talking point: "We see $4M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $40M in equity value creation."